References

Citations

1. Mutch DG (2008). Uterine cancer. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 1002–1021. Philadelphia: Lippincott Williams and Wilkins.

2. American College of Obstetricians and Gynecologists (2005, reaffirmed 2007). Management of endometrial cancer. ACOG Practice Bulletin No. 65. Obstetrics and Gynecology, 106(2): 413–425.

3. Burke TW, et al. (2001). Cancers of the uterine body. In VT DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 6th ed., chap. 36-3, pp. 1573–1594. Philadelphia: Lippincott Williams and Wilkins.

4. American Joint Committee on Cancer (2002). Corpus uteri. In AJCC Cancer Staging Manual, 6th ed., pp. 267–273. New York: Springer-Verlag.

5. Cannistra SA (2007). Gynecologic cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 10. New York: WebMD.

6. Smith RA, et al. (2008). Cancer screening in the United States, 2008: A review of current American Cancer Society guidelines and cancer screening issues. CA: A Cancer Journal for Clinicians, 58: 161–179.

7. Chu CS, et al. (2008). Cancers of the uterine body. In VT DeVita et al., eds., DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, 7th ed., vol. 2, pp. 1543–1563. Philadelphia: Lippincott Williams and Wilkins.

8. Schmeler KM, et al. (2006). Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. New England Journal of Medicine, 354(3): 261–269.

9. Ramirez PT, et al. (2004). Hormonal therapy for the management of grade I endometrial adenocarcinoma: A literature review. Gynecologic Oncology, 95: 133–138.

10. Randall ME, et al. (2006). Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Journal of Clinical Oncology, 24(1): 36–44.

11. National Cancer Institute (2008). Endometrial Cancer Treatment (PDQ): Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/healthprofessional.

12. Horn-Ross PL, et al. (2003). Phytoestrogen intake and endometrial cancer risk. Journal of the National Cancer Institute, 95(15): 1158–1164.

13. Abramowicz M (2003). Treatment guidelines: Drugs of choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41–52.

14. Creutzberg CL, et al. (2000). Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. Lancet, 355: 1404–1411.